Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1979 1
1981 2
1983 3
1985 1
1986 1
1988 3
1990 2
1991 1
1992 2
1995 2
1996 1
1997 3
1998 3
1999 3
2001 1
2002 1
2004 1
2005 4
2006 4
2007 4
2008 1
2009 2
2010 1
2012 2
2013 1
2014 2
2015 4
2018 1
2019 2
2020 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Synthetic T cell receptor-based lymphocytes for cancer therapy.
Getts D, Hofmeister R, Quintás-Cardama A. Getts D, et al. Among authors: hofmeister r. Adv Drug Deliv Rev. 2019 Feb 15;141:47-54. doi: 10.1016/j.addr.2019.04.002. Epub 2019 Apr 12. Adv Drug Deliv Rev. 2019. PMID: 30981835 Review.
Interleukin-7: physiological roles and mechanisms of action.
Hofmeister R, Khaled AR, Benbernou N, Rajnavolgyi E, Muegge K, Durum SK. Hofmeister R, et al. Cytokine Growth Factor Rev. 1999 Mar;10(1):41-60. doi: 10.1016/s1359-6101(98)00025-2. Cytokine Growth Factor Rev. 1999. PMID: 10379911 Review.
Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response.
Baeuerle PA, Ding J, Patel E, Thorausch N, Horton H, Gierut J, Scarfo I, Choudhary R, Kiner O, Krishnamurthy J, Le B, Morath A, Baldeviano GC, Quinn J, Tavares P, Wei Q, Weiler S, Maus MV, Getts D, Schamel WW, Hofmeister R. Baeuerle PA, et al. Among authors: hofmeister r. Nat Commun. 2019 May 7;10(1):2087. doi: 10.1038/s41467-019-10097-0. Nat Commun. 2019. PMID: 31064990 Free PMC article.
Toxicological safety evaluation of gadobutrol.
Wack C, Steger-Hartmann T, Mylecraine L, Hofmeister R. Wack C, et al. Among authors: hofmeister r. Invest Radiol. 2012 Nov;47(11):611-23. doi: 10.1097/RLI.0b013e318263f128. Invest Radiol. 2012. PMID: 23011188
58 results